Thiogenesis Therapeutics, Corp. (TSXV:TTI)
Canada · Delayed Price · Currency is CAD 0.5400
+0.0400 (8.00%)
At close: Apr 10, 2026
Thiogenesis Therapeutics Market Cap
Thiogenesis Therapeutics has a market cap or net worth of CAD 27.99 million as of April 10, 2026. Its market cap has decreased by -10.55% in one year.
Market Cap
27.99M
Enterprise Value
24.49M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.54
Market Cap Chart
Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 27.99M, an increase of 100.58%. That is a compound annual growth rate of 19.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 27.99M | -16.92% |
| Dec 31, 2025 | 33.69M | 22.03% |
| Dec 31, 2024 | 27.61M | -17.40% |
| Dec 29, 2023 | 33.43M | 48.30% |
| Dec 30, 2022 | 22.54M | 61.52% |
| Apr 13, 2022 | 13.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medicenna Therapeutics | 54.22M |
| MedMira | 45.61M |
| BriaCell Therapeutics | 42.49M |
| Defence Therapeutics | 40.82M |
| Devonian Health Group | 33.37M |
| Resverlogix | 33.20M |
| Microbix Biosystems | 33.13M |
| Telescope Innovations | 31.92M |